Cited by 303Blood Pressure and Hypertension StudiesCardiovascular Health and Disease PreventionHormonal Regulation and Hypertension

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

High prevalence of cardiac and extracardiac target organ damage in refractory hypertension

Abstract

OBJECTIVE: Target organ damage (TOD) in chronically treated hypertensives is related to effective blood pressure (BP) control. The aim of this study was to evaluate the prevalence of cardiac and extracardiac TOD in patients with refractory hypertension (RH) compared with well-controlled treated hypertensives (C). METHODS: Fifty-four consecutive patients with RH (57 +/- 10 years), selected according to WHO/ISH guidelines definition, and 51 essential hypertensives (55 +/- 10 years) with satisfactory BP control obtained by association therapy, underwent the following procedures: (1) clinic BP measurement; (2) blood sampling for routine chemistry examinations; (3) 24 h urine collection for microalbuminuria; (4) non-mydriatic retinography; (5) echocardiogram; (6) carotid ultrasonogram. In order to exclude 'office resistance' (defined as clinic BP > 140/90 mmHg and average 24 h BP </= 125/79 mmHg), all patients with RH were subjected to 24-hour ambulatory BP monitoring. RESULTS: Both groups were similar for age, gender, body surface area, smoking habit and duration of hypertension, glucose, creatinine and lipid levels. By definition, clinic BP was significantly higher in RH than C (161 +/- 19/96 +/- 9 versus 127 +/- 6/80 +/- 5 mmHg, respectively, P < 0.01). The increased prevalence of left ventricular hypertrophy (LVH) and carotid intima-media (IM) thickening (40 versus 12%, P < 0.01, according to a non-gender-specific partition value of 125 g/m2; and 36 versus 14%, P < 0.01, according to IM thickness > or =1.0 mm, respectively); a higher prevalence of carotid plaques (65 versus 32%, P < 0.05), a more advanced retinal involvement (grade II and III, 73 and 5% versus 38 and 0%, P < 0.01) and a greater albumin urinary excretion (22 +/- 32 mg/24 h versus 11 +/- 13 mg/24 h, P < 0.01) were found in RH compared to C. CONCLUSIONS: Our study suggests that RH is a clinical condition associated with a high prevalence of TOD at cardiac, macro- and microvascular level and consequently with high absolute cardiovascular risk, which needs a particularly intensive therapeutic approach aimed to normalize BP levels and to induce TOD regression.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004872-200111000-00018

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Obesity, left ventricular hypertrophy, albuminuria, diabetes mellitus, chronic kidney disease, higher Framingham 10-year risk score, and obstructive sleep apnea are more common in resistant hypertension than non-resistant hypertension.

    “Obesity,39–41 left ventricular hypertrophy,42 albuminuria,14,43 diabetes mellitus,14,38,39 CKD,38,39,44 higher Framingham 10-year risk score,39 and obstructive sleep apnea (OSA)45,46 are more common in RH than non-RH.”
  • Physiological aberrations in resistant hypertension include vascular disease/dysfunction as evidenced by high rates of peripheral and carotid artery atherosclerosis, impaired endothelial function, reduced arterial compliance, and raised systemic vascular resistance, all of which may be more pronounced in resistant hypertension compared with non-resistant hypertension.

    “Physiological aberrations in RH include vascular disease/dysfunction as evidenced by high rates of peripheral39 and carotid artery atherosclerosis,42 impaired endothelial function,51,52 reduced arterial compliance, and raised systemic vascular resistance,40 all of which may be more pronounced in RH compared with non-RH.”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. &NA;, 1997, Arch Intern Med, 157, 2413, 10.1001/archinte.157.21.2413 · DOI · Paper page
  2. Mogensen, 1991, Adv Nephrol, 20, 191
  3. Hernandez-del Rey, 1998, Blood Press Monit, 3, 331
  4. 1999, J Hypertens, 17, 151
  5. Ciulla, 2000, Ital Heart J, 1, 233

Cited by

Sorted by citations

Metadata

Authors
Cuspidi, C., Macca, G., Sampieri, L., Michev, I., Salerno, M., Fusi, V., Severgnini, B., Meani, S., Magrini, F., & Zanchetti, A.
Affiliations
University of Milan (IT)
Corresponding author
Cuspidi, Cesare
Venue
Journal of Hypertension
Published
2001-11
Volume
19
Issue
11
Pages
2063-2070
ISSN
0263-6352 (ISSN-L)
OpenAlex
W2092430951
Cited by
303
References
46
Citations by year
2026: 8 · 2025: 2 · 2024: 9 · 2023: 11 · 2022: 4 · 2021: 6 · 2020: 8 · 2019: 9 · 2018: 8 · 2017: 9 · 2016: 15 · 2015: 19 · 2014: 32 · 2013: 35 · 2012: 34
FWCI
2.92
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
resistant hypertension, target organ damage, left ventricular hypertrophy, carotid intima-media thickening, carotid plaque, retinal involvement, microalbuminuria, ambulatory blood pressure monitoring, essential hypertension, blood pressure control, hypertension prevalence, echocardiography, retinal imaging, carotid ultrasound, 24-hour urine
MeSH terms
Albuminuria, Carotid Artery Diseases, Echocardiography, Humans, Hypertension, Retinal Diseases, Prevalence, Hypertrophy, Left Ventricular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review